SouthState Corp’s United Therapeutics UTHR Stock Holding History

SouthState Corp’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.19K	Buy	2 +1	+100%	+$498	﹤0.01%	1008
2025 Q4	$488	Hold	1	–	–	﹤0.01%	1244
2025 Q3	$420	Sell	1 -1	-50%	-$336	﹤0.01%	1265
2025 Q2	$575	Sell	2 -4	-67%	-$1.2K	﹤0.01%	1407
2025 Q1	$1.85K	Buy	+6	New	+$2.06K	﹤0.01%	1202

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

SouthState Corp's UTHR Position: Q1 2026 in Review

SouthState Corp increased its United Therapeutics (UTHR) stake by 100% in Q1 2026, buying an estimated $498 and bringing the position to 2 shares worth $1.19K. The position accounts for ﹤0.01% of the portfolio, ranked #1008.

SouthState Corp first reported a position in UTHR in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.85K in Q1 2025. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

SouthState Corp held 2 shares of United Therapeutics worth $1.19K as of Q1 2026.
SouthState Corp bought 1 United Therapeutics share in Q1 2026, an estimated $498.
United Therapeutics made up ﹤0.01% of SouthState Corp's portfolio in Q1 2026, its #1008 holding.
SouthState Corp first reported a position in United Therapeutics in Q1 2025 and has held it in 5 quarters since.
SouthState Corp's United Therapeutics position peaked at $1.85K in Q1 2025.
850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on SouthState Corp's 13F filing for Q1 2026, filed 5 May 2026.